Title: Medical management of reflux esophagitis
Authors: Vantrappen, Gaston ×
Janssens, Jozef #
Issue Date: Jan-1986
Series Title: Digestion vol:32 Suppl 1 pages:51-8
Abstract: Esophageal reflux should be treated only if symptoms are severe enough for patients to seek therapy or if esophagitis results. One study found that the number of reflux episodes lasting more than 5 min was the best indicator of esophagitis. Factors such as efficiency of the antireflux barrier, esophageal clearing, and aggressive power of refluxed material impact on the pathogenesis of reflux esophagitis. Therapy should be aimed at these factors and depends on severity of disease. Dietary measures, postural measures, and drug therapy can be used to alleviate symptoms and/or improve healing of esophageal lesions, with surgery recommended only in rare cases. Antacids, Gaviscon, and motor-stimulating drugs (metoclopramide, domperidone, bethanechol) may be sufficient to treat pathologic reflux without esophagitis. Once erosive or ulcerative lesions have developed, more rigorous medical treatment including H2 receptor blockers is mandatory.
ISSN: 0012-2823
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Translational Research in GastroIntestinal Disorders
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science